Coldstream Capital Management Inc. Boosts Stock Holdings in MetLife, Inc. (NYSE:MET)

Coldstream Capital Management Inc. increased its position in shares of MetLife, Inc. (NYSE:MET) by 2.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,140 shares of the financial services provider’s stock after buying an additional 487 shares during the period. Coldstream Capital Management Inc.’s holdings in MetLife were worth $1,273,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MET. GoalVest Advisory LLC grew its position in shares of MetLife by 73.3% during the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 165 shares during the period. Pineridge Advisors LLC purchased a new position in MetLife during the fourth quarter worth approximately $39,000. Bank & Trust Co acquired a new stake in MetLife in the second quarter valued at approximately $39,000. Crewe Advisors LLC increased its position in shares of MetLife by 602.5% in the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after buying an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC raised its stake in shares of MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock worth $40,000 after buying an additional 239 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.

MetLife Stock Up 0.1 %

Shares of MET opened at $74.74 on Thursday. MetLife, Inc. has a 52-week low of $57.91 and a 52-week high of $79.34. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The stock has a fifty day simple moving average of $73.62 and a two-hundred day simple moving average of $72.20. The company has a market capitalization of $53.15 billion, a PE ratio of 25.68, a price-to-earnings-growth ratio of 0.59 and a beta of 1.04.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.15. The firm had revenue of $17.82 billion during the quarter, compared to analysts’ expectations of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. MetLife’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $1.94 earnings per share. As a group, equities analysts forecast that MetLife, Inc. will post 8.67 EPS for the current year.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 10th. Investors of record on Tuesday, August 6th were given a $0.545 dividend. The ex-dividend date was Tuesday, August 6th. This represents a $2.18 annualized dividend and a yield of 2.92%. MetLife’s payout ratio is 74.91%.

Wall Street Analyst Weigh In

Several brokerages recently commented on MET. Citigroup boosted their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Bank of America decreased their price target on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Wells Fargo & Company boosted their price objective on MetLife from $85.00 to $86.00 and gave the stock an “overweight” rating in a research note on Monday, August 12th. Keefe, Bruyette & Woods decreased their target price on MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a research report on Monday, July 8th. Finally, JPMorgan Chase & Co. boosted their price target on MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 2nd. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $84.54.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.